Direct and Indirect Utilization and Costs Associated with Ulcerative Colitis | Zendy

Russell D. Cohen | Zendy; Joanne Rizzo | Zendy; Min Yang | Zendy; Melissa Diener | Zendy; Mei Yang | Zendy; Martha Skup | Zendy; Parvez Mulani | Zendy; Jingdong Chao | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Direct and Indirect Utilization and Costs Associated with Ulcerative Colitis

Author(s) -

Russell D. Cohen,

Joanne Rizzo,

Min Yang,

Melissa Diener,

Mei Yang,

Martha Skup,

Parvez Mulani,

Jingdong Chao

Publication year - 2012

Publication title -

the american journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.907

H-Index - 252

eISSN - 1572-0241

pISSN - 0002-9270

DOI - 10.1038/ajg.2012.275

Subject(s) - medicine , absenteeism , indirect costs , ulcerative colitis , medical prescription , sick leave , vedolizumab , multivariate analysis , medical costs , demographics , emergency department , inflammatory bowel disease , disease , demography , physical therapy , health care , business , accounting , management , psychiatry , sociology , economic growth , economics , pharmacology

Inflammatory bowel disease (IBD) is a term used to describe ulcerative colitis and Crohn's disease. Both are chronic, lifelong conditions characterised by periods of exacerbation and remission. The management of IBD is complex for the health care team. Following an exploration of the physical, psychological and sociological impact of the condition, the medications used to control the symptoms are described, together with consideration of the surgical options used in the management of IBD. Finally, the role of the nurse in meeting holistically the needs of patients with IBD is highlighted.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research